+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Sentinel-node biopsy or nodal observation in melanoma

Sentinel-node biopsy or nodal observation in melanoma

New England Journal of Medicine 355(13): 1307-1317

We evaluated the contribution of sentinel-node biopsy to outcomes in patients with newly diagnosed melanoma. Patients with a primary cutaneous melanoma were randomly assigned to wide excision and postoperative observation of regional lymph nodes with lymphadenectomy if nodal relapse occurred, or to wide excision and sentinel-node biopsy with immediate lymphadenectomy if nodal micrometastases were detected on biopsy. Among 1269 patients with an intermediate-thickness primary melanoma, the mean (+/-SE) estimated 5-year disease-free survival rate for the population was 78.3+/-1.6% in the biopsy group and 73.1+/-2.1% in the observation group (hazard ratio for recurrence[corrected], 0.74; 95% confidence interval [CI], 0.59 to 0.93; P=0.009). Five-year melanoma-specific survival rates were similar in the two groups (87.1+/-1.3% and 86.6+/-1.6%, respectively). In the biopsy group, the presence of metastases in the sentinel node was the most important prognostic factor; the 5-year survival rate was 72.3+/-4.6% among patients with tumor-positive sentinel nodes and 90.2+/-1.3% among those with tumor-negative sentinel nodes (hazard ratio for death, 2.48; 95% CI, 1.54 to 3.98; P<0.001). The incidence of sentinel-node micrometastases was 16.0% (122 of 764 patients), and the rate of nodal relapse in the observation group was 15.6% (78 of 500 patients). The corresponding mean number of tumor-involved nodes was 1.4 in the biopsy group and 3.3 in the observation group (P<0.001), indicating disease progression during observation. Among patients with nodal metastases, the 5-year survival rate was higher among those who underwent immediate lymphadenectomy than among those in whom lymphadenectomy was delayed (72.3+/-4.6% vs. 52.4+/-5.9%; hazard ratio for death, 0.51; 95% CI, 0.32 to 0.81; P=0.004). The staging of intermediate-thickness (1.2 to 3.5 mm) primary melanomas according to the results of sentinel-node biopsy provides important prognostic information and identifies patients with nodal metastases whose survival can be prolonged by immediate lymphadenectomy. (ClinicalTrials.gov number, NCT00275496 [ClinicalTrials.gov].).

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 060237224

Download citation: RISBibTeXText

PMID: 17005948

DOI: 10.1056/nejmoa060992

Related references

Sentinel-node biopsy or nodal observation in melanoma. Current Oncology Reports 9(5): 401, 2007

Final trial report of sentinel-node biopsy versus nodal observation in melanoma. New England Journal of Medicine 370(7): 599-609, 2014

Sentinel lymph node biopsy or nodal observation in melanoma: study of an Italian series. Giornale Italiano di Dermatologia e Venereologia 148(3): 299-305, 2013

Sentinel lymph node biopsy or nodal observation in melanoma: a prospective study of patient choices. Dermatologic Surgery 37(2): 199-206, 2011

Sentinel Lymph Node Biopsy or Nodal Observation in Melanoma: a Prospective Study of Patient Choices. Yearbook of Dermatology and Dermatologic Surgery 2012: 444-445, 2012

Sentinel node biopsy or nodal observation. Current Oncology Reports 9(5): 401-402, 2007

Sentinel node biopsy and selective dissection for melanoma nodal metastases. Tumori 84(1): 24-28, 1998

Regression in thin melanoma is associated with nodal recurrence after a negative sentinel node biopsy. Cancer Medicine 5(10): 2832-2840, 2016

US scan and sentinel node biopsy in the diagnosis of nodal metastases in patients with melanoma. European Journal of Cancer 37(Suppl. 6): S82, 2001

Preoperative ultrasound is not useful for identifying nodal metastasis in melanoma patients undergoing sentinel node biopsy: preoperative ultrasound in clinically node-negative melanoma. Annals of Surgical Oncology 19(4): 1100-1106, 2012

Role of lymphatic mapping and sentinel node biopsy in the detection of melanoma nodal metastases. European Journal of Cancer 34(Suppl. 3): S7-11, 1998

Predictors for Use of Sentinel Node Biopsy and the Association with Improved Survival in Melanoma Patients Who Have Nodal Staging. Annals of Surgical Oncology 25(4): 903-911, 2018

Sentinel lymph node biopsy in patients with thin melanoma: occurrence of nodal metastases and its prognostic value. European Journal of Dermatology 20(1): 30-34, 2010

The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group study. European Journal of Surgical Oncology 42(12): 1906-1913, 2016

High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma. European Journal of Cancer 42(3): 372-380, 2006